Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New digital tool helps east asian cancer patients plan care with family

NCT ID NCT06035549

First seen Jan 30, 2026 · Last updated Jun 23, 2026 · Updated 17 times

Summary

This study is creating a digital program to help East Asian immigrants with cancer build resilience and start conversations about advance care planning with their families. Researchers will interview religious leaders and test the tool with 84 patients to see if it is easy to use and acceptable. The goal is to make these discussions more comfortable by addressing cultural beliefs and barriers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Illinois Chicago

    RECRUITING

    Chicago, Illinois, 60607, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Culturally tailored digital resilience-building intervention

What this could lead to

If successful, this could provide a practical digital tool that helps East Asian immigrants with cancer have important conversations about their care wishes with family.

What could go wrong

This is a small, early-stage study focused on developing and testing usability, not on health outcomes. The tool may not be widely adopted or effective in real-world settings.

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.